methylene blue/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases intensive care unit length of stay
StrongEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.Finding“The results showed that MB reduced the ICU LOS in patients with distributive shock (MD: −1.54; 95% CI −2.61 to −0.48; p=0.004; I2=25%; table 2).”
Quoted verbatim from Effect of methylene blue on outcomes in patients with distributive shock: a meta-analysis of randomised controlled trials.. - Study
- meta-analysis
- Participants
- 141
- Population
- adults with distributive shock (septic shock, vasoplegic syndrome, ischaemia-reperfusion injury); secondary endpoint; 3 trials, n = 141
Effect -1.54 mean difference, 95% CI -2.61 to -0.48
Effect of methylene blue on outcomes in patients with distributive shock: a meta-analysis of randomised controlled trials.2024PMID:38216185Permalink
Keep reading
- Everything the graph holds on methylene blue
- Every compound studied against Intensive care unit length of stay
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M107NF3WYZ0SS97GTR904RQ8